|
[1]
|
Mancini, T., Kola, B., Mantero, F., et al. (2004) High Cardiovascular Risk in Patients with Cushing’s Syndrome According to 1999 WHO/ISH Guidelines. Clinical Endocrinology (Oxford), 61, 768-777. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Scaroni, C., Zilio, M., Foti, M., et al. (2017) Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management. Endocrine Reviews, 38, 189-219. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Alberti, K.G. and Zimmet, P.Z. (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation. Diabetic Medicine, 15, 539-553. [Google Scholar] [CrossRef]
|
|
[4]
|
Pivonello, R., De Leo, M., Vitale, P., et al. (2010) Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome. Neuroendocrinology, 92, 77-81. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Bodine, S.C. and Furlow, J.D. (2015) Glucocorticoids and Skeletal Muscle. Advances in Experimental Medicine and Biology, 872, 145-176. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kuo, T., Harris, C.A., Wang, J.C.J.M., et al. (2013) Metabolic Functions of Glucocorticoid Receptor in Skeletal Muscle. Molecular and Cellular Endocrinology, 380, 79-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Barbot, M., Ceccato, F. and Scaroni, C. (2018) Diabetes Mellitus Secondary to Cushing’s Disease. Frontiers in Endocrinology (Lausanne), 9, 284. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Sherwin, R.S., Shamoon, H., Hendler, R., et al. (1980) Epinephrine and the Regulation of Glucose Metabolism: Effect of Diabetes and Hormonal Interactions. Metabolism, 29, 1146-1154. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Kappe, C., Fransson, L., Wolbert, P., et al. (2015) Glucocorticoids Suppress GLP-1 Secretion: Possible Contribution to Their Diabetogenic Effects. Clinical Science (London), 129, 405-414. [Google Scholar] [CrossRef]
|
|
[10]
|
Eriksen, M., Jensen, D.H., Tribler, S., et al. (2015) Reduction of Insulinotropic Properties of GLP-1 and GIP after Glucocorticoid-Induced Insulin Resistance. Diabetologia, 58, 920-928. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Munir, A. and Newell-Price, J. (2010) Management of Diabetes Mellitus in Cushing’s Syndrome. Neuroendocrinology, 92, 82-85. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
冯凯, 陆召麟, 臧美孚. 162例库欣综合征糖代谢异常的临床资料分析[J]. 中国医学科学院学报, 2000, 22(3): 266-268.
|
|
[13]
|
Burt, M.G., Roberts, G.W., Aguilar-Loza, N.R., et al. (2011) Continuous Monitoring of Circadian Glycemic Patterns in Patients Receiving Prednisolone for COPD. The Journal of Clinical Endocrinology & Metabolism, 96, 1789-1796. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Burt, M.G., Willenberg, V.M., Petersons, C.J., et al. (2012) Screening for Diabetes in Patients with Inflammatory Rheumatological Disease Administered Long-Term Prednisolone: A Cross-Sectional Study. Rheumatology (Oxford), 51, 1112-1119. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Otsuki, M., Kitamura, T., Tamada, D., et al. (2016) Incompatibility between Fasting and Postprandial Plasma Glucose in Patients with Cushing’s Syndrome. Endocrine Journal, 63, 1017-1023. [Google Scholar] [CrossRef]
|
|
[16]
|
Li, G., Han, L., Ma, R., et al. (2019) Glucocorticoids Increase Renal Excretion of Urate in Mice by Downregulating Urate Transporter 1. Drug Metabolism & Disposition, 47, 1343-1351. [Google Scholar] [CrossRef] [PubMed]
|